Localized accumulation of fat tissue at injection sites, caused by repeated injections in the same area. Prevented by systematic rotation of injection sites across abdomen, thighs, and upper arms.
"Lipohypertrophy" is filed under Administration in the PeptideAtlas glossary, alongside 15 other terms in that group.
1 other glossary entry refer to this term in their own definition, which is usually the fastest way to see how it is used in practice.
The practice of alternating injection locations (abdomen, thighs, upper arms) to prevent lipohypertrophy, scar tissue formation, and ensure consistent absorption.
An injection administered into the fatty tissue layer between the skin and muscle. The most common route for peptide self-administration.
An injection administered directly into a muscle. Some peptides may be administered via IM injection under medical supervision.
Administration directly into a vein. Provides 100% bioavailability but requires medical supervision and sterile technique.
Terms that reference this one: Injection Site Rotation.
More Administration terms: Subcutaneous (SubQ), Intramuscular (IM), Intravenous (IV), Intranasal, Sublingual, Topical Peptide, Transdermal, Microneedle Patch, Insulin Syringe, Titration, Loading Dose, Maintenance Dose, Peptide Stack, Injection Site Rotation, Intranasal Delivery.